766 related articles for article (PubMed ID: 4575649)
41. Cellular and humoral immune responses of cancer patients to defined tumor antigens.
Jäger D; Jäger E; Bert F; Knuth A
Cancer Chemother Biol Response Modif; 2001; 19():385-93. PubMed ID: 11686025
[No Abstract] [Full Text] [Related]
42. [Current problems in immunology].
Ambrosius H
Z Gesamte Inn Med; 1974 Apr; 29(8):309-15. PubMed ID: 4137395
[No Abstract] [Full Text] [Related]
43. Studies of tumor antigens and tumor-specific immune mechanisms in experimental systems.
Law LW
Transplant Proc; 1970 Mar; 2(1):117-32. PubMed ID: 4330038
[No Abstract] [Full Text] [Related]
44. [Basic principles of transplantation immunology].
Land W; Brendel W
Fortschr Kiefer Gesichtschir; 1976; 20():1-10. PubMed ID: 131100
[No Abstract] [Full Text] [Related]
45. [Tumor immunology. Experience in man].
Oettgen HF; Gallmeier WM
Dtsch Med Wochenschr; 1968 Jun; 93(23):1157-61. PubMed ID: 4872860
[No Abstract] [Full Text] [Related]
46. [Cancer and the lymphatic system].
Grekh IF
Vopr Onkol; 1971 Sep; 17(10):101-10. PubMed ID: 4947716
[No Abstract] [Full Text] [Related]
47. Tumour specific transplantation antigens in animal and human tumours and the therapeutic implications of the development of humoral and cellular immunity to such antigens.
Sirsi M
Indian J Cancer; 1972 Dec; 9(4):337-9. PubMed ID: 4656227
[No Abstract] [Full Text] [Related]
48. [Immunotherapy of cancer, using anaerobic corynebacteria].
Halpern B
Acquis Med Recent; 1972; ():95-113. PubMed ID: 4542887
[No Abstract] [Full Text] [Related]
49. [Tumor-specific immunotherapy: active immunotherapy by augmenting the induction of tumor-specific effector T cells through a T-T cell interaction mechanism].
Kosugi A; Fujiwara H; Hamaoka T
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1527-35. PubMed ID: 6236750
[TBL] [Abstract][Full Text] [Related]
50. Introduction to immunology.
Barber HR
Prog Clin Biol Res; 1981; 70():3-16. PubMed ID: 6975946
[No Abstract] [Full Text] [Related]
51. Relationship between blocking and unblocking activity and tumor growth in vivo.
Sjögren HO; Bansal SC
Natl Cancer Inst Monogr; 1972 Dec; 35():231-5. PubMed ID: 4349148
[No Abstract] [Full Text] [Related]
52. An overview of cancer immunology.
Ritts RE; Neel HB
Mayo Clin Proc; 1974 Feb; 49(2):118-31. PubMed ID: 4591299
[No Abstract] [Full Text] [Related]
53. Regulatory mechanisms in tumor immunity: introduction and summary.
Rich RR
Fed Proc; 1981 Jan; 40(1):36-8. PubMed ID: 6450064
[No Abstract] [Full Text] [Related]
54. [Preferential efficicacy of immunocomplexes in the facilitation of tumor allografts].
Duc HT; Kinsky RG; Voisin GA
Ann Immunol (Paris); 1973 Nov; 124(4):567-72. PubMed ID: 4134880
[No Abstract] [Full Text] [Related]
55. Tumor immunity and immunotherapy.
Boura P; Kountouras J; Lygidakis NJ
Hepatogastroenterology; 2001; 48(40):1040-4. PubMed ID: 11490795
[TBL] [Abstract][Full Text] [Related]
56. [Introduction to the International Symposium on Tumor Immunotherapy].
De Barbieri A
Boll Ist Sieroter Milan; 1971; 50(3):137-9. PubMed ID: 5146576
[No Abstract] [Full Text] [Related]
57. BCG in cancer and leukemia treatment and prophylaxis-A review.
Rosenthal SR
J Med; 1975; 6(3-4):193-212. PubMed ID: 1104732
[TBL] [Abstract][Full Text] [Related]
58. [Regulatory problems in tumor immunology].
Pasternak G
Allerg Immunol (Leipz); 1973; 19(2-4):307-19. PubMed ID: 4281633
[No Abstract] [Full Text] [Related]
59. Immune reactions to neoplastic disease.
Cottier H
Adv Exp Med Biol; 1973; 29(0):449-54. PubMed ID: 4794959
[No Abstract] [Full Text] [Related]
60. Immunotherapy of human leukemia.
Baker MA; Taub RN
Mt Sinai J Med; 1972; 39(6):548-65. PubMed ID: 4565179
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
